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Abstract (250 words):   39 
 40 
During malaria blood stage infections, Plasmodium parasites interact with the red blood cell (RBC) surface 41 
to enable invasion followed by intracellular proliferation. Critical factors involved in invasion have been 42 
identified using biochemical and genetic approaches including specific knockdowns of genes of interest 43 
from primary CD34+ hematopoietic stem cells (cRBCs). Here, we report the development of a robust in 44 
vitro culture system to produce RBCs that allow for generation of gene knockouts via CRISPR/Cas9 using 45 
the immortal JK-1 erythroleukemia line. JK-1 cells spontaneously differentiate, generating cells at different 46 
stages of erythropoiesis, including terminally differentiated nucleated RBCs that we term “jkRBCs”. A 47 
screen of small molecule epigenetic regulators identified several bromodomain-specific inhibitors that 48 
promote differentiation, and enable production of synchronous populations of jkRBCs. Global surface 49 
proteomic profiling revealed that jkRBCs express all known P. falciparum host receptors in a similar 50 
fashion to cRBCs and multiple P. falciparum strains invade jkRBCs at comparable levels to cRBCs and RBCs. 51 
Using CRISPR/Cas9 we deleted two host factors (BSG and CD44) for which no natural nulls exist. BSG 52 
interacts with the parasite ligand Rh5, a prominent vaccine candidate. A BSG knockout was completely 53 
refractory to parasite invasion in a strain-transcendent manner, confirming the essential role for BSG 54 
during invasion. CD44 was recently identified in an RNAi screen of blood group genes as a host factor for 55 
invasion, and we show that a CD44 knockout results in strain-transcendent reduction in invasion. 56 
Furthermore we demonstrate a functional interaction between these two determinants in mediating P. 57 
falciparum erythrocyte invasion.  58 
 59 
 60 
Significance statement (120 words):    61 
During malaria infections, Plasmodium falciparum parasites invade red blood cells (RBCs). Identification 62 
of host factors for parasite invasion guides the development of vaccines and host-targeted therapeutics. 63 
In this work we describe the development of an in vitro culture system for the functional analysis of red 64 
blood cell determinants using the immortal erythroleukemia cell line JK-1. JK-1 cells can be induced to 65 
differentiate synchronously, support parasite invasion and are amenable to genetic manipulation. Using 66 
this system we validated two host factors, BSG and CD44, as strain transcendent host factors for parasite 67 
invasion and we demonstrated a functional interaction between these two proteins. The ability to 68 
perform gene editing to produce RBC mutants will augment our ability to study malaria infection. 69 
  70 
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Introduction 71 
 72 
Malaria is an infectious disease caused by Plasmodium parasites and is a major public health burden with 73 
upwards of 200 million cases and over 400,000 deaths annually (1). Upon infection of a new host, the 74 
parasite replicates in a liver cell following which it establishes a cyclical infection of red blood cells (RBCs), 75 
leading to all of the clinical symptoms of disease (2). Invasion of new RBCs occurs rapidly after release of 76 
daughter merozoites from mature schizonts (3), and during the invasion process parasites use multiple 77 
invasion ligands to bind to the host RBC by interacting with specific host receptors (4-6). Blocking these 78 
interactions can lead to a reduction in parasite invasion (7), a strategy underlying blood-stage vaccine 79 
design (8, 9). 80 
 81 
Fundamental insights into host-parasite interactions during invasion have come from analysis of rare 82 
naturally occurring RBC polymorphisms (10) or through biochemical interaction studies using recombinant 83 
invasion ligands and recombinant host receptor panels (7, 11). We have focused on a genetic approach, 84 
which requires using CD34+ hematopoietic stem cells (HSCs) (12, 13) that allows systematic generation of 85 
RBC genetic mutants. Using this system, we have functionally characterized the effects of knockdown of 86 
the host receptor GypA on the invasion of the sialic-acid dependent P. falciparum strain W2mef (14).  87 
 88 
There are several challenges with using primary CD34+ HSCs that include: (i) the short time-frame for 89 
introducing gene knockdowns during erythroid differentiation which may limit the extent of knockdown 90 
and precludes obtaining clonal cell populations; (ii) primary cell differentiation is terminal leading to the 91 
need to repeatedly generate gene knockdowns for each assay; (iii) invasion screening and functional 92 
characterization of gene knockdowns requires large numbers of cells which can be costly to generate. The 93 
broad range of genetic techniques facilitated byt the the Clustered Regularly Interspaced Short 94 
Palindromic Repeats (CRISPR)/Cas9 system (15-19) is highly desirable for modifying RBC host factors to 95 
investigate Plasmodium invasion, but the use of these techniques remains challenging in primary CD34+ 96 
cells (20, 21).  97 
 98 
Here we have developed an in vitro culture system using the immortal JK-1 erythroleukemia cell (22), 99 
that permits the rapid and efficient generation of RBC genetic mutants and overcomes the challenges of 100 
using primary CD34+ HSCs. JK-1 cells spontaneously differentiate at low rates to form cells that resemble 101 
young, nucleated RBCs. We have developed methods for enriching differentiated cells, and to reduce 102 
heterogeneity we screened a library of epigenetic regulators for compounds that induce differentiation. 103 
Importantly, the differentiated JK-1 cells support invasion by P. falciparum, and combined with the ability 104 
to genetically modify the cells provides a platform for the functional characterization of host factors 105 
important for parasite invasion. Using this system, we have generated a knockout of the essential host 106 
receptor basigin (BSG), for which no natural nulls exist, and which binds the parasite invasion ligand Rh5 107 
(23, 24) now a leading vaccine candidate (9). We show that the BSG knockout line is completely refractory 108 
for parasite invasion, thus validating BSG as an essential receptor for P. falciparum invasion (9, 25).  109 
 110 
In a recent shRNA-based forward genetic screen of 42 blood group genes, we identified two host 111 
factors important for parasite invasion (CD55 and CD44) (26). CD55 was functionally characterized as an 112 
essential host factor for invasion through use of natural CD55 RBC null cells, however similar natural nulls 113 
were not available for CD44. Using the JK-1 cell system, we have generated a CD44 knockout and we show 114 
that this knockout line displays a pronounced reduction in invasion across multiple parasite strains, 115 
confirming the importance of CD44 for P. falciparum invasion. As CD44 has been reported to interact with 116 
BSG (27-29) we investigated the functional significance of this interaction by using an α-BSG antibody to 117 
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inhibit invasion. We find that the CD44 knockout enhances the α-BSG-dependent inhibition of invasion, 118 
indicating a functional interaction between BSG and CD44 during parasite invasion. 119 
 120 
Results 121 
 122 
JK-1 erythroleukemia cells models erythropoiesis in vitro 123 
 124 
While P. falciparum preferentially invades mature RBCs, it is also capable of invading nucleated RBCs, 125 
primarily orthochromatic erythroblasts (14, 26, 30). As such, we were interested in testing the ability of 126 
immortal erythroleukemia cell lines to differentiate, form RBCs and support parasite invasion. A search of 127 
the literature identified ten different erythroleukemia cell lines that we were able to obtain and culture 128 
in the laboratory: Ery-1 (31); K562 (32); KH88/C2F8 (33); B4D6 (33); LAMA-84 (34); TF-1A (35); HEL92.1.7 129 
(36); OCIM (37); OCIM-2 (37); and JK-1 (22) (Supplementary Figure 1A). During routine culture, we 130 
observed spontaneous differentiation into predominantly polychromatic-like nucleated RBCs (38) in only 131 
the JK-1 cell-line. The JK-1 erythroleukemia cell line was isolated from an individual with Philadelphia-132 
chromosome positive chronic myelogenous leukemia and is reported to express HbF (22). A typical JK-1 133 
culture produced a stochastically fluctuating mixture of erythroid-like cells at different sizes and stages of 134 
differentiation (Figure 1). A majority (>80%) of actively dividing cells was composed of less differentiated 135 
proerythroblasts and basophilic erythroblasts. The differentiated nucleated RBCs in the JK-1 cell-line 136 
consisted of primarily early- and late-stage polychromatic erythroblasts, with a very small fraction (<1%) 137 
of orthochromatic erythroblasts (characterized by fully condensed nuclei (38)) and occasional (<0.5%) 138 
enucleated cells (resembling reticulocytes).  139 
 140 
 Given the heterogeneity of normal JK-1 cell cultures, we tested a number of different techniques to 141 
specifically enrich for different cell populations. We observed that cell size varied based on the stage of 142 
differentiation with undifferentiated proerythroblasts having almost 2-fold larger diameter than 143 
differentiated polychromatic and orthochromatic erythroblasts (Figure 1A). We first tested whether we 144 
could use fluorescent activated cell sorting (FACS) to separate cells based on size. Using forward scatter 145 
(FSC) and side scatter (SSC) parameters, we found a gate that resulted in the enrichment of basophilic, 146 
early and late-stage polychromatic cells (small cell gate) and a gate that enriched for proerythroblasts 147 
(large cell gate) (Supplementary Figure 1B). As FACS is time and resource intensive for sorting large 148 
numbers of cells, we next tested whether we could enrich cells using a bulk method. As Percoll density 149 
gradients have been used to enrich for hematopoietic cells from bone marrow extracts (39), we tested 150 
whether this method would be feasible for JK-1 cells. Centrifuging a mixed population of JK-1 cells through 151 
a 52.5% (v/v) Percoll-PBS gradient resulted in an ~15-fold enrichment of differentiated early- and late-152 
stage polychromatic cells in the cell pellet, while proerythroblasts and basophilic erythroblasts were 153 
retained at the interface between the Percoll gradient and the culture media (Figure 1B). We found that 154 
the Percoll-PBS method was faster than FACS and was simple to scale up for large numbers (>108) of cells. 155 
 156 
Bromodomain inhibition induces differentiation of JK-1 cells 157 
 158 
While FACS and Percoll-PBS allowed us to enrich for differentiated jkRBCs, only a relatively small 159 
proportion (10 – 15%) of a typical JK-1 culture contained differentiated cells. Therefore we were 160 
interested in finding ways of increasing the proportion of differentiated nucleated RBCs in a synchronous 161 
manner. We hypothesized that as JK-1 cells display spontaneous differentiation, that this process might 162 
be under epigenetic control, and indeed epigenetic regulators have been reported to induce cellular 163 
differentiation (40-42). We screened an epigenetic library for small molecule inducers of differentiation. 164 
To begin with we required a method of quantitatively monitoring JK-1 differentiation. We observed that 165 
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expression of glycophorin A (GypA), a cell surface marker of erythrocyte maturation (43, 44), was 166 
correlated with JK-1 differentiation (Supplementary Figure 2A). Using a FITC-labelled α-GypA antibody we 167 
observed two distinct populations: the GypA-negative fraction (gated based on unstained cells) contained 168 
predominantly proerythroblasts and basophilic erythroblasts while the GypA-high fraction was enriched 169 
for early- and late-stage polychromatic cells. 170 
 171 
Using this method we sorted for a population of GypA-negative JK-1 cells and screened these cells 172 
with a library of 96 epigenetic modifiers (Cayman Chemicals, USA). This library includes small molecules 173 
that target a wide variety of epigenetic regulatory proteins. Two rounds of screening were performed with 174 
cells harvested after 5 days in screen 1 and after both 7 and 14 days in screen 2. Upon harvest, the levels 175 
of GypA were measured by flow cytometry and the ratio of GypA-high:GypA-negative was calculated 176 
(Supplementary Figure 2B). The data from the screen were ranked by hierarchical clustering (Figure 2A; 177 
Supplementary Table 1). Six compounds were identified that displayed substantial induction of JK-1 cell 178 
differentiation. Significantly, four of the six top compounds included inhibitors of bromodomain-179 
containing proteins: two compounds (+)-JQ1 (45) and PFI-1 (46) target mammalian bromodomain and 180 
extra terminal domain (BET) proteins; bromosporine is a general bromodomain inhibitor (47); and I-181 
CBP112 targets the bromodomain of cAMP-responsive element-binding protein binding protein 182 
(CREBBP)/E1A-associated protein p300 (EP300) (48, 49). The only other bromodomain-specific inhibitor 183 
in the library, PFI-3, targets a different category of bromodomain-containing protein (50) and was not 184 
found to be an inducer of JK-1 differentiation. The two other top inducers, GSK343 (51) and UNC1999 (52) 185 
both target the catalytic core of the polycomb repressive complex 2 (PRC2) enhancer of zeste homologue 186 
2 (EZH2) histone methyltransferase (53).  187 
 188 
We validated two top hits, PFI-1 and (+)-JQ1, by testing differentiation with a range of concentrations 189 
of compound (Figure 2B). In both cases, at high concentrations of compound, cell expansion was inhibited, 190 
while at the lowest concentration of compound, cell growth was similar to the DMSO-treated control cells 191 
for the first six days following which the cell expansion plateaued. We next monitored cells treated with 192 
the optimal concentrations of PFI-1 (2 µM) and (+)-JQ1 (1 µM) during differentiation by staining for GypA 193 
and CD34, which is a marker for early hematopoietic stem cells (43) (Figure 3A). Both PFI-1 and (+)-JQ1 194 
treatment led to a rapid increase of GypA surface levels resulting in a homogenous population of GypA-195 
positive cells by 8 days post-induction while the un-induced control had a broad mixture of cells with 196 
different levels of GypA. CD34 levels also decreased rapidly and were almost undetectable by day 4 in the 197 
induced conditions but remained at a low level in the control cells. Analysis of cell morphology (Figure 3B) 198 
demonstrated that both PFI-1 and (+)-JQ1 treatment resulted in the formation of differentiated cells, 199 
whereas the DMSO-treated control cells remained a mixed population. When PFI-1 and (+)-JQ1 are tested 200 
in combination (Supplementary Figure 2C,D), differentiation is still observed but with reduced cell 201 
expansion.  202 
 203 
Inhibition with LSD1 inhibitors maintains an undifferentiated state   204 
 205 
While the primary focus of the epigenetic screen was to identify compounds that induce synchronous 206 
differentiation, we were also interested to see if there were compounds that had the opposite effect. In 207 
the screen (Figure 2A) we observed a number of compounds that had low levels of differentiation as 208 
measured by α-GypA staining. Examination of the flow cytometry data for these compounds over the 209 
different days of the assay indicated that the majority of this effect was due to toxicity of the compounds, 210 
as the initial GypA-negative population had not expanded. However, we identified one compound, the 211 
lysine specific demethylase 1 (LSD1) inhibitor (tranylcypromine), which was able to maintain growth of 212 
cells in an undifferentiated state. When a population of GypA-negative cells was treated with 213 
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tranylcypromine, the cells grew at the same rate as DMSO-treated control cells, doubling once every ~ 30 214 
hours (Supplementary Figure 2E). Tranylcypromine treated cells retained similar levels of GypA, CD34 and 215 
CD71 (transferrin receptor) over multiple generations, while DMSO-treated controls showed pronounced 216 
increases in GypA levels and reduction of CD34 levels over the same period (Supplementary Figure 2F).  217 
 218 
JkRBCs functionally resemble nucleated RBCs 219 
 220 
Having identified epigenetic factors that could control JK-1 differentiation, we next tested the 221 
synchronicity of the differentiated cells. Starting with cells maintained on 10 µM tranylcypromine, we 222 
induced differentiation of these cells with 2 µM PFI-1 and between 12 – 14 days post-induction, cells were 223 
harvested and passaged through 52.5% (v/v) PBS-Percoll. The resulting cells displayed a high degree of 224 
homogeneity and consisted of >90% late-stage polychromatic cells (Figure 3C). Next we compared these 225 
jkRBCs to bone marrow-derived CD34+ HSCs (cRBCs) and peripheral RBCs. The cRBCs were at day 16 post 226 
thaw and consisted of a mixture of cells including basophilic erythroblasts, early- and late-stage 227 
polychromatic erythroblasts, orthochromatic erythroblasts, reticulocytes and pyrenocytes (ejected 228 
nuclei) (Supplementary Figure 3A). Analysis of three independent biological cRBC cultures at 16 – 17-days 229 
post-thaw showed that a majority of cells were orthochromatic erythroblasts and reticulocytes (together 230 
> 70%), while earlier stage basophilic and polychromatic erythroblasts were present at much lower 231 
frequencies (< 10%) (Supplementary Figure 3B). A comparison of cell diameter showed that the jkRBCs 232 
(Figure 1A) were ~ 1.25-fold larger on average than the dominant cRBCs (orthochromatic erythroblasts 233 
and reticulocytes). During the process of P. falciparum invasion, the parasite interacts with numerous host 234 
surface membrane proteins on the surface of peripheral RBCs. In order to check whether jkRBCs expressed 235 
known host receptors, we performed flow cytometry to compare the levels of expression of BSG, GypA, 236 
GypC, CR1 and CD71 between jkRBCs, cRBCs and peripheral RBCs (Figure 3D). The relative flow cytometry 237 
signal for three of the known host receptors (GypA, GypC and CR1) were tightly correlated between 238 
jkRBCs, cRBCs and peripheral RBCs. The level of BSG was higher in jkRBCs and cRBCs and about 10-fold 239 
lower in peripheral RBCs, suggesting that levels of this protein change substantially during the final stages 240 
of erythroid maturation. As a control we measured the levels of transferrin receptor (CD71), which is 241 
abundant on jkRBCs and cRBCs but is absent from peripheral RBCs, as has been observed previously (54, 242 
55). 243 
 244 
 We next performed a global analysis of the surface membrane protein composition of jkRBCs by 245 
quantitative surface proteomics (26, 56). We identified 237 surface membrane proteins by ≥ 2 peptides, 246 
from a total of 677 identified proteins (Supplementary Table 2). We compared this dataset to available 247 
RBC proteomes (Supplementary Figure 3C) and were able to identify 92.2% of the jkRBC proteins in one 248 
or more of the published proteomes. The dataset with the greatest overlap (85.9%) included proteomes 249 
of not only mature RBCs, but also erythroid progenitors (57). Next we used quantitative surface 250 
proteomics to compare the relative abundance of surface membrane proteins between jkRBCs and an 251 
equal number of day 16 cRBCs. The relative abundance of a large proportion (68.6%) of the cRBC 252 
membrane proteins was within ± 2-fold of the equivalent jkRBC proteins, and 91.1% were within a ± 4-253 
fold range (Figure 3E). A comparison of the blood group proteins (Supplementary Figure 3D) showed a 254 
similar pattern. The majority of proteins, including known P. falciparum host receptors GypA, GypC, CR1 255 
and BSG, were within a 2-fold range. By this method, we are not able to distinguish GypA and GypB, so 256 
the signal we observe for GypA is a combination of GypA and GypB. We also identified three proteins with 257 
greater than 4-fold abundance (BCAM, CD99, SLC14A1) in cRBCs compared to jkRBCs.  258 
 259 
JkRBCs support invasion by P. falciparum  260 
 261 
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We next tested the ability of jkRBCs to support P. falciparum invasion as has been observed for other 262 
nucleated erythroid precursors (14, 30, 58). Indeed we observed invasion into jkRBCs by two different 263 
strains of P. falciparum: the sialic acid-independent strain 3D7 (59) and the sialic acid-dependent strain 264 
Dd2 (60) (Figure 4A). To compare invasion efficiency of P. falciparum into jkRBCs, cRBCs and RBCs we 265 
measured the parasitized erythrocyte multiplication rate (PEMR) (% final ring parasitemia/% initial 266 
schizontemia) between the different cell types. The invasion rates of P. falciparum strains 3D7 and Dd2 267 
into jkRBCs were comparable to invasion into cRBCs and RBCs (Figure 4B), suggesting that jkRBCs express 268 
sufficient levels of all relevant host receptors and possess the requisite glycosylation required for parasite 269 
binding and invasion (4, 6). Since we often observed multiple parasites invading into a single host jkRBC, 270 
we quantified the preference for multiple parasite invasion events by determining the selectivity index 271 
(SI) (61) (Supplementary Figure 3E). The SI is a measure of the observed number of multiply-infected cells 272 
compared to the number expected by chance based on a Poisson distribution, and can be used to 273 
determine the susceptibility of host cells to invasion by Plasmodium parasites. The jkRBCs showed the 274 
highest SI followed by cRBCs and RBCs. To determine whether P. falciparum parasites grew normally in 275 
jkRBCs, we assessed parasite growth during a single cycle (Supplementary Figure 4). While parasites were 276 
occasionally observed to develop into trophozoites and schizonts, development of these stages was 277 
significantly impeded compared to RBCs. 278 
 279 
Generation of a BSG knockout via CRISPR/Cas9 280 
 281 
We next tested if it was possible to genetically manipulate the JK-1 cells. We transduced the JK-1 cells 282 
with a lentivirus expressing an shRNA targeting GYPA and monitored protein levels by flow cytometry. We 283 
were able to detect a substantial decrease in GypA protein expression within about 1 week post-284 
transduction (Supplementary Figure 5A) thus confirming that shRNA gene knockdowns were supported 285 
by JK-1 cells. We then attempted to generate gene knockouts using the CRISPR/Cas9 gene editing system 286 
(19) (Supplementary Figure 5B). We chose the human BSG gene encoding the basigin receptor (Ok blood 287 
group (62)), which is an essential receptor for P. falciparum (7). We first generated lentivirus containing 288 
the LentiCas9-Blast plasmid (19) and introduced it by viral transduction into JK-1 cells. Cells were selected 289 
by growth on blasticidin until a stable JK-1-Cas9 cell line was obtained. No toxicity or difference in growth 290 
rate associated with Cas9 expression was observed. Next, three single-guide RNAs (sgRNAs) targeting BSG 291 
were individually cloned into the LentiGuide-Puro vector (19) and these constructs were virally transduced 292 
into the LentiCas9-positive JK-1 cells. After 2 – 4 weeks of selection, single cell clones were obtained by 293 
limiting dilution of the bulk population. The presence of gene knockouts in these clonal cell lines was 294 
assessed by loss of α-BSG flow cytometry staining and subsequently verified by Sanger sequencing and 295 
Tracking of Indels by Decomposition (TIDE) analysis (Supplementary Figure 5C-E). Of the three sgRNAs we 296 
tested, we only observed one single-guide that showed a complete loss of α-BSG flow staining in the bulk 297 
population (BSG-1 sgRNA), and following cloning two individual clonal lines were obtained (ΔBGS-1 and 298 
ΔBSG-2) from this sgRNA, both with different deletions in each gene copy (Supplementary Figure 5C,D). 299 
The BSG-1 sgRNA targeted the N-terminus of the BSG protein and the resulting deletions disrupted the 300 
initiator methionine ATG codon (Supplementary Figure 5E). 301 
 302 
In order to validate the BSG knockout jkRBCs did not have any RBC developmental defects, we 303 
compared the expression levels of BSG, GypA, GypC and CR1 by flow cytometry for JK-1 wildtype and 304 
ΔBSG jkRBCs (Figure 5A). The ΔBSG cells showed a complete loss of α-BSG signal, confirming a functional 305 
loss of BSG protein. The levels of GypA, GpyC and CR1 were very similar between the WT and ΔBSG lines. 306 
To further confirm that deletion of BSG did not result in changes to any other surface membrane protein, 307 
we compared the abundance of surface proteins from ΔBSG jkRBCs to wild type jkRBCs using quantitative 308 
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surface proteomics (Figure 5B, Supplementary Table 2). Our data demonstrate that the knockout of BSG 309 
was specific and did not lead to the significant alteration of other surface membrane proteins. 310 
 311 
BSG is essential for P. falciparum invasion 312 
 313 
Basigin is proposed to be an essential receptor for P. falciparum (7) and we have previously demonstrated 314 
that knockdown of BSG in CD34+ HSCs via shRNA leads to a substantial decrease (~80%) in invasion by 315 
multiple strains of P. falciparum (7). While there is strong evidence that BSG is an essential receptor for P. 316 
falciparum, the residual invasion observed with the BSG knockdown (7) raised some doubts about 317 
whether loss of BSG would completely block P. falciparum invasion. There are natural BSG polymorphisms 318 
that occur as part of the Ok blood group (62), but to date no natural BSG nulls have been described. To 319 
determine the effect of deleting BSG in jkRBCs, we performed invasion assays with two different strains 320 
of P. falciparum (3D7 and Dd2) using two independent BSG knockout clones (ΔBSG-1 and ΔBSG-2), both 321 
generated using the BSG-1 sgRNA. We observed a complete inhibition of invasion into both ΔBSG clones 322 
for both P. falciparum strains (Figure 5C). This result provides strong evidence that BSG is required for 323 
strain-transcendent invasion. 324 
 325 
CD44 is a strain-transcendent invasion host factor  326 
 327 
CD44 was identified as a potential host receptor during a screen of blood group gene knockdowns (26). 328 
Knockdowns of CD44 in CD34+ HSCs led to a modest reduction in P. falciparum invasion, but this was only 329 
tested in the 3D7 strain and functional characterization of CD44 was limited by the lack of naturally 330 
occurring CD44 nulls. Therefore, we generated a knockout of CD44 using CRISPR/Cas9 and we obtained 331 
mutant cells with an insertion in the exon 2 that leads to the formation of a premature stop codon and 332 
truncation of the protein in the N-terminal extracellular domain (Supplementary Figure 6A,B). We 333 
confirmed the knockout of CD44 was specific by flow cytometry (Supplementary Figure 6C) and 334 
quantitative surface proteomics (Figure 6A) where we did not observe a significant change in abundance 335 
specifically of any known host receptor (BSG, GypA, GypC, CR1) or other surface membrane protein. We 336 
next tested invasion of multiple P. falciparum strains into two CD44 knockout clonal lines (ΔCD44-1 and 337 
ΔCD44-2) and we observed a consistent inhibition of invasion (between ~ 30 – 40%) across multiple 338 
parasite strains including the sialic acid independent 3D7 and sialic acid dependent W2mef strains (Figure 339 
6B), confirming the importance of CD44 in P. falciparum invasion. 340 
 341 
 342 
CD44 functionally interacts with BSG 343 
 344 
CD44 has been reported to interact with BSG in multiple cancer cell lines (27-29) prompting us to test 345 
whether there was a functional interaction between CD44 and BSG. To do so, we used the monoclonal 346 
MEM6/6 α-BSG antibody, which has previously been shown to inhibit parasite invasion (7), to inhibit P. 347 
falciparum 3D7 invasion into JK-1 wild type and ΔCD44-1 cells (Figure 6C). We observed an approximately 348 
2-fold reduction in IC50 for the ΔCD44-1 knockouts compared to WT JK-1 cells, indicating that the ΔCD44-349 
1 knockout cells were more sensitive to inhibition by the α-BSG antibody. We next checked if this could 350 
be explained by differences in levels of BSG on JK-1 WT and ΔCD44-1 knockout cells. However, we did not 351 
observe any significant difference in BSG protein levels either by flow cytometry (Supplementary Figure 352 
6D) or by quantitative surface proteomics (Supplementary Table 2). Next we tested the effect of inhibition 353 
of an invasion step downstream of Rh5/BSG by using the R1 peptide that inhibits the interaction between 354 
the parasite factors AMA1 and RON2, which are involved in strong attachment of the invading merozoite 355 
(Figure 6D) (63, 64). In this case we observed an approximately 2-fold increase in IC50 in the ΔCD44-1 356 
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knockout compared to the JK-1 WT, indicating an increased utilization of the AMA1/RON2 interaction in 357 
the absence of CD44. 358 
 359 
Discussion 360 
 361 
A major area of interest in Plasmodium biology has been the identification of essential, strain 362 
transcendent host receptors since their cognate invasion ligands may be potent vaccine candidates (9). 363 
We have developed an in vitro culture system for functional analysis of the host contribution to blood-364 
stage Plasmodium falciparum invasion using the JK-1 erythroleukemia cell line, which displayed unique 365 
features: (i) JK-1 cells naturally produced erythroid lineage cells (proerythroblast-, basophilic-, 366 
polychromatic- and orthochromatic-like cells) and using small-molecule epigenetic modifiers, we were 367 
able to either maintain the cells in an undifferentiated state or to predictably induce synchronous 368 
differentiation to produce jkRBCs (nucleated RBCs). (ii) JkRBCs functionally resembled differentiated 369 
cRBCs and peripheral RBCs. The surface membrane protein composition of jkRBCs was comparable in 370 
composition to cRBCs and peripheral RBCs, and known P. falciparum host receptors were expressed at 371 
levels equal to or greater than RBCs and cRBCs. Critically, jkRBCs supported robust invasion of multiple P. 372 
falciparum strains, implying the presence of all the requisite host factors were at sufficient levels for 373 
parasite invasion. (iii) JK-1 cells were readily amenable to different genetic modifications such as gene 374 
knockdowns via RNAi and gene knockouts via CRISPR/Cas9, which have been challenging in primary CD34+ 375 
HSCs (20, 21). (iv) As JK-1 cells are immortal, we were able to generate clonal mutant cell lines and were 376 
able to freeze down, thaw and cost-effectively produce large numbers of wild type and mutant cells.  377 
 378 
In our screen for epigenetic factors that induce synchronous differentiation of JK-1 cells, the most 379 
potent inducers targeted bromodomain-containing proteins. Bromodomain proteins bind to acetylated ε-380 
amino lysine residues on histones and are involved in the regulation of gene expression (65, 66). The two 381 
top inducers of JK-1 differentiation, (+)-JQ1 and PFI-1, despite having different chemical scaffolds, target 382 
BET family proteins which consists of four members: BRD2, BRD3, BRD4 and BRDT (67, 68). BET family 383 
proteins are involved in multiple transcription complexes and help regulate cell growth (69). In the context 384 
of erythropoiesis, they promote chromatin occupancy of acetylated forms of the global erythroid 385 
transcription factor GATA-1 (70, 71) which itself modulates gene expression during erythropoiesis. With 386 
the ability to genetically manipulate JK-1 cells, it may be possible to elicit controlled induction of 387 
differentiation independent of epigenetic regulators, by directly controlling levels of BET protein 388 
expression, e.g. by knock-in of destabilization domain tags (72). 389 
 390 
The composition of the surface membrane proteome of jkRBCs shares a high degree of overlap with 391 
published RBC proteomes. Our quantitative surface proteomics analysis comparing cRBCs and jkRBCs 392 
showed that >90% of proteins were expressed within a 4-fold range. Instances of higher protein 393 
abundance on jkRBCs compared to cRBCs and RBCs (e.g. BSG) may be explained by: (i) the overall larger 394 
size of jkRBCs compared to cRBCs and RBCs; (ii) the greater homogeneity and relative immaturity of jkRBCs 395 
(late-stage polychromatic cells) compared to cRBCs (orthochromatic cells and reticulocytes); (iii) and the 396 
overall decrease in protein abundance per cell during erythropoiesis (57). While we observed variation in 397 
the levels of surface membrane proteins, jkRBCs supported equivalent P. falciparum invasion rates as 398 
cRBCs, indicating that none of the essential host receptors is limiting. However it is possible that the 399 
variation in surface membrane protein levels may result in differences in invasion between jkRBCs and 400 
cRBCs/peripheral RBCs when host receptor levels are modified (e.g. by enzyme treatment or by knockout 401 
of non-essential receptors).  402 
 403 
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One limitation of jkRBCs is the relative immaturity of these cells compared to cRBCs, as judged by the 404 
larger average size, higher levels of CD71 and deficiency in forming reticulocytes. These features likely 405 
stem from the cancer-causing mutations (22) that favor continued cell replication instead of terminal 406 
differentiation. JK-1 cells have double Philadelphia chromosomes, which is typically linked with the 407 
formation of the BCR-ABL kinase oncogene (73). The relative immaturity of jkRBCs and the expression of 408 
HbF (22) may explain the delayed growth of P. falciparum post-invasion. A similar effect has been 409 
observed with parasite invasion into younger CD34+ basophilic and polychromatic erythroblasts (30). In 410 
order to study parasite growth we could either (i) screen for genetic mutations in JK-1 cells that support 411 
parasite growth and/or (ii) adapt parasites to growth in JK-1 cells by long-term propagation as has been 412 
shown for P. knowlesi adaptation to growth in human reticulocytes (74).  413 
 414 
The JK-1 cell culture system has facilitated functional characterization of two host factors (BSG and 415 
CD44) important in P. falciparum invasion. BSG null cells have not been found naturally and strain-416 
transcendent inhibition with BSG was demonstrated using anti-BSG or anti-RH5 antibodies, often at high 417 
concentrations (7, 25, 75). We have previously generated a BSG knockdown by RNAi in CD34+ HSCs, which 418 
showed ~ 80% reduction in invasion efficiency (7). We hypothesized that the remaining invasion could be 419 
due to residual BSG protein present on the knockdown cells. Using the JK-1 system and CRISPR/Cas9 to 420 
generate ΔBSG cell lines has allowed us to confirm that the loss of BSG expression results in complete 421 
inhibition of invasion of multiple parasite strains, thus confirming the essential role that BSG plays in 422 
parasite invasion.  423 
 424 
CD44 was identified as an invasion host factor in a forward genetic RNAi screen of blood group genes 425 
(26), but its role in invasion could not be fully characterized due to the absence of natural CD44 null cells. 426 
We observed that knockout of CD44 resulted in consistent reduction of invasion efficiency, in a strain-427 
transcendent fashion, confirming the importance of CD44 as a host factor for P. falciparum invasion. 428 
Furthermore, we observed a functional interaction between CD44 and BSG, as measured by a reduction 429 
in IC50 of the α-BSG MEM6/6 antibody in ΔCD44-1 knockout cells compared to JK-1 WT. This effect is not 430 
simply due to decreased levels of BSG in the ΔCD44-1 knockout cells. Other possible explanations include 431 
CD44 functioning either directly as a host receptor at an earlier stage than the Rh5/BSG interaction (76) – 432 
in this case loss of CD44 would result in reduced number of parasites successfully reaching the Rh5/BSG 433 
step of invasion. Alternatively, based on the reported CD44/BSG interaction (27-29), CD44 could be 434 
operating directly as a co-receptor with BSG and could be prompting the parasite to preferentially utilize 435 
a subset of BSG bound to CD44 during invasion.  436 
 437 
In contrast to the effect of inhibition of Rh5/BSG, we observed an increase in IC50 of the R1 peptide 438 
inhibition of AMA1/RON2 in the ΔCD44 knockout compared to the JK-1 WT. AMA1 and RON2 are parasite-439 
derived factors that are host receptor independent and mediate strong attachment of the merozoite (63, 440 
64) at a step downstream of the Rh5/BSG interaction (76). Similar antagonistic effects of inhibition of 441 
Rh5/BSG and AMA1/RON2 have been reported previously (77, 78). As the CD44 knockout is synergistic 442 
with BSG inhibition, and as AMA1 and RON2 are parasite-derived, we suggest that the CD44 function maps 443 
with BSG rather than AMA1/RON2. Therefore, one possible consequence of loss of CD44 (based on the 444 
limited-area model for invasion-ligand/host-receptor interactions (79)) may be the reduced engagement 445 
of an earlier invasion ligand (e.g. Rh5). As such there would be a subsequent increase in the available 446 
space for AMA1/RON2 at the apical end of the merozoite during RBC attachment (77, 79), thus resulting 447 
in an increased utilization of the AMA1/RON2 pathway. Of great interest with regards the function of 448 
CD44 during invasion include the identification of any potential parasite invasion ligand, the effect of 449 
previously reported CD44 interaction with cytoskeletal proteins band 4.1 and ankyrin (80) and possible 450 
signaling roles of CD44 during invasion, either separately or in parallel with BSG (81). 451 
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 452 
The versatility of the JK-1 in vitro culture system in supporting both robust parasite invasion and 453 
simple genetic manipulation to produce gene knockouts will facilitate the functional analysis of the host 454 
contribution to P. falciparum invasion. Indeed, the identification and characterization of essential and 455 
strain-transcendent host factors and the parasite molecules with which they interact is a vital aspect of 456 
understanding parasite invasion biology and will ultimately aid in the development of vaccines and host-457 
targeted therapeutics.  458 
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Materials and Methods 459 
 460 
Cell culture 461 
The following eythroleukemia cell lines were obtained from the Leibniz Institute DSMZ-German Collection 462 
of Microorganisms and Cell Cultures: JK-1 (catalogue #ACC347), OCIM-1 (ACC529), OCIM-2 (ACC619) and 463 
LAMA84 (ACC168). The following erythroleukemia cell lines were obtained from the American Type 464 
Culture Collection: HEL 92.1.7 (TIB-180), K562 (CCL-243) and TF-1A (CRL-2451). The C2F8 and B4D6 cell 465 
lines were kind gifts of Dr. Tatsuo Furukawa (Niigata University School of Medicine, Japan) (33). The Ery-466 
1 cell line was a kind gift of Dr. Michael Arock (Unité CNRS UMR 8147, Paris, France) (31). The 467 
erythroleukemia cell lines were propagated in Iscove’s Modified Dulbecco’s Medium (IMDM) with 468 
Glutamax (Thermo Fisher Scientific) and supplemented with 0.5% (v/v) penicillin/streptomycin (Thermo 469 
Fisher Scientific) and either 10% AB+ heat-inactivated serum (Interstate Blood Bank) or 10% AB+ 470 
octaplas®LG (OctoPharma) with 2 IU/mL heparin (Affymetrix). Cells were maintained at between 1 x 471 
105/mL to 1 x 106/mL in vented T-flasks (BDFalcon) at 37°C in a humidified chamber with 5% (v/v) CO2. 472 
When necessary, cells were frozen in growth media + 5% (v/v) dimethylsulfoxide (Sigma-Aldrich). JK-1 473 
clones were obtained by limiting dilution and all subsequent experiments were performed with the JK-1-474 
7B clone. CD34+ hematopoietic stem cells (Lonza) were cultured as described previously (12, 13, 26). 475 
Cytospins were prepared as described previously (26) and stained with May-Grünwald (Sigma-Aldrich) 476 
followed by Giemsa (Sigma-Aldrich) according to the manufacturer’s instructions. A double-chamber 477 
Neubauer hemocytometer (VWR) was used for live cell counting. 478 
 479 
Percoll density gradients 480 
The Percoll (GE Healthcare) density gradients were prepared based on modifications to an existing 481 
protocol (39), by mixing stock Percoll (100%) to the indicated final volumetric dilution (e.g. 52.5% (v/v)) 482 
with 1 volume of 10X PBS (final concentration 1X) and the remainder with ddH2O. The pH was adjusted to 483 
7.40 with HCl, following which the mixture was filtered through a 0.2 μm sterile filter (Millipore). Typically 484 
4 mL of the gradients were added to a 15 mL Falcon tube and a suspension of cells in 4 mL IMDM + 10% 485 
AB+ media were gently layered on top of the Percoll cushion. The cells were pelleted at 500 g for 10 486 
minutes with low acceleration and low braking. Following the centrifugation, the interface and pellet 487 
fractions were transferred to separate 15 mL Falcon tubes and washed 2x with IMDM.  488 
 489 
Flow cytometry and fluorescent activated cell sorting 490 
For flow cytometry, between 1 – 5 x 105 cells were washed into flow buffer (PBS + 0.5% (w/v) BSA) and 491 
allowed to bind to antibodies for 30 minutes at room temperature and protected from light. The following 492 
antibodies and dilutions were used: 1 in 200 AlexaFluor 647 goat-α-mouse (Thermo Fisher Scientific); 1 in 493 
100 α-BSG-FITC (ThermoFisher Scientific); 1 in 20 α-CD34-FITC (Miltenyi Biotech); 1 in 20 α-CD71-APC 494 
(Miltenyi Biotech); 1 in 100 α-CR1 (Santa Cruz Biotechnology); 1 in 100 α-GypA-FITC (StemCell 495 
Technologies); 1 in 2000 α-GypC-FITC (Santa Cruz Biotechnology); 1 in 20 α-CD44-APC (Miltenyi Biotech). 496 
Samples were washed in flow buffer and analyzed on a Milteny MACSQuant instrument equipped with 497 
405 nm, 488 nm and 638 nm lasers and an autosampler. During flow cytometry measurements, cells were 498 
stained with propidium iodide (Miltenyi Biotec, San Diego, CA) to exclude live/dead cells. Flow cytometry 499 
data were analyzed using FlowJo v 10.2. For FACS analysis, cells were sorted on a BioRad S3 cell sorter 500 
equipped with both 488 nm and 561 nm lasers.  501 
 502 
Epigenetic library screening 503 
A focused library of 96 epigenetic modifiers (Cayman Chemicals) was screened for the ability to induce 504 
differentiation of JK-1 cells. Undifferentiated JK-1 cells were obtained by FACS by gating for an α-GypA-505 
FITC-negative population. In the first experimental run, cells were diluted to 4.0 x 104 cells/well in 200 μL 506 
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JK-1 growth media in 96-well flat-bottom plates (Falcon) and epigenetic modifiers were added to 10 μM 507 
or 1 μM final concentration using the robotics facility at the Institute of Chemistry and Cell Biology at 508 
Harvard Medical School. Cells were grown for 5 days under standard growth conditions prior to 509 
harvesting. In the second experimental run, cells were diluted to 8.0 x 103 cells/well with the same two 510 
concentrations of epigenetic modifiers (10 μM and 1 μM). Half of the cells were harvested 7-days post 511 
setup and the media was refreshed for the remainder of the cells which were allowed to grow until 14-512 
days post setup. The harvested cells were stained with α-GypA-FITC and the level of GypA was measured 513 
by flow cytometry on a Miltenyi MACSQuant (Miltenyi). The ratio of GypA-high:GypA-negative was 514 
calculated from plots of SSC vs α-GypA-FITC (see Supplementary Figure 2A,B) for each compound and the 515 
values were normalized to the highest ratio for each concentration of each experimental run. The data 516 
were clustered using Gene Cluster v3.0 (82) by hierarchical clustering with a Euclidean distance similarity 517 
metric and complete linkage. The data were visualized using TreeView v1.1.6r4 (83).  518 
 519 
Cloning and Lentivirus Generation 520 
GuideRNA target sequences were identified bioinformatically using the Broad Institute Genetic 521 
Perturbation Platform sgRNA designer tool (https://portals.broadinstitute.org/gpp/public/analysis-522 
tools/sgrna-design) (84). Primers for the top three hits for BSG and CD44 were synthesized (Integrated 523 
DNA Technologies, Coralville, Iowa): BSG-1-F 5ʹ-CACCGGCGAGGAATAGGAATCATGG; BSG-1-RC 5ʹ-524 
AAACCCATGATTCCTATTCCTCGCC; BSG-2-F 5ʹ-CACCGTCTTCATCTACGAGAAGCGC; BSG-2-RC 5ʹ- 525 
AAACGCGCTTCTCGTAGATGAAGAC; BSG-3-F 5ʹ- CACCGCGTTGCACCGGTACTGGCCG; BSG-3-RC 5ʹ- 526 
AAACCGGCCAGTACCGGTGCAACGC; CD44-1-F 5ʹ- CACCGCGTGGAATACACCTGCAAAG; CD44-1-RC 5ʹ-527 
AAACCTTTGCAGGTGTATTCCACGC; CD44-2-F 5ʹ- CACCGACTGATGATGACGTGAGCAG; CD44-2-RC 5ʹ- 528 
AAACCTGCTCACGTCATCATCAGTC; CD44-3-F 5ʹ-CACCGCTGTGCAGCAAACAACACAG; CD44-3-RC 5ʹ- 529 
AAACCTGTGTTGTTTGCTGCACAGC. Primer pairs were phosphorylated using T4 polynucleotide kinase 530 
(New England Biolabs) and ligated using Quick Ligase (New England Biolabs) into the LentiGuide-Puro 531 
vector (19), which had previously been digested with BsmBI (Thermo Fisher Scientific) and 532 
dephosphorylated with FastAP alkaline phosphatase (Thermo Fisher Scientific). Ligated plasmids were 533 
transformed into Stbl3 bacteria (Thermo Fisher Scientific) and selected with 100 μg/mL carbenicillin on 534 
Luria-Bertani agar plates. Correctly-integrated sgRNAs were confirmed by Sanger sequencing using the U6 535 
promoter: 5ʹ-GACTATCATATGCTTACCGT (19). Plasmid DNA was purified using MaxiPreps (Qiagen) and 536 
used to generate lentivirus using established protocols (85) 537 
 538 
CRISPR/Cas9 knockouts 539 
CRISPR/Cas9 knockouts were generated following existing protocols (17, 19). First JK-1 cells were 540 
transduced with the LentiCRISPR-Blast vector and selected with 6 μg/mL blasticidin (Sigma-Aldrich). The 541 
basticidin-resistant cells were next transduced with the LentiGuide-Puro vectors containing each of the 542 
three BSG sgRNAs and cells were selected for by growing with both 6 μg/mL blasticidin and 2 μg/mL 543 
puromycin (Sigma-Aldrich). Knockout generation were monitored by flow cytometry and once cultures 544 
had >50% knockout cells, the population was cloned by limiting dilution. Of the 3 sgRNAs tested only BSG-545 
1 resulted in generation of BSG knockouts. Individual clones were screened by Sanger sequencing using 546 
the following primer sets: BSG-1-seq-F 5ʹ- AAGCAGGAAGGAAGAAATG; BSG-1-seq-RC 5ʹ- 547 
TTCACGCCCACACACAGAG followed by TIDE analysis (86) to find bi-allelic knockouts. For CD44, of the 3 548 
tested sgRNAs, only CD44-1 Resulted in generation of CD44 knockouts. The DNA region around the target 549 
site was PCR amplified using the following primers, CD44-1-seq-F 5ʹ-AGCGAATTCTGGGATTGTAGGCATGAG 550 
and CD44-1-seq-RC 5ʹ-TGTCTAGAGGTGCTGGTCTCTTACCTG, digested with EcoRI (NEB) and XbaI (NEB), 551 
ligated into a carrier plasmid and transformed into XL-10 Gold cells (Agilent) to obtain bacterial clones. 552 
The DNA sequence around the sgRNA cut site was subsequently obtained by Sanger sequencing.  553 
 554 
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Quantitative Surface Proteomics 555 
Plasma membrane profiling was performed as described (56, 87) using 2 x 107 of two batches of wild-type 556 
jkRBCs, one batch each of the two different ΔBSG clones, one batch each of the two different CD44 clones 557 
and one batch of day 16 CD34+ cRBCs. Surface membrane proteins were identified following labeling of 558 
sialic acid residues with aminooxy-biotin and after processing and generation of tryptic peptides, these 559 
were labeled with isobaric tandem mass tags (56) in a 1:1:1:1:1:1:1 ratio. These labeled peptides were 560 
enriched and subjected to mass spectrometry as described in supplementary methods.  561 
 562 
Invasion assays 563 
All parasite assays were performed with either P. falciparum 3D7 attB::TdTomato or P. falciparum Dd2 564 
attB::TdTomato strains unless otherwise indicated (see Supplementary Materials for description of these 565 
lines). Parasites were cultured following established protocols (88, 89) at 2% hematocrit in O+ blood 566 
(Interstate Blood Bank) in complete RPMI media with 0.5% (w/v) albumax and 0.2% (w/v) sodium 567 
bicarbonate at 37°C with 5% (v/v) CO2 and 1% (v/v) O2. Invasion assays were performed as described (14, 568 
26, 77). Typically invasion assays were prepared with 0.5 – 1.5 x 106 cells in 50 μL complete IMDM media 569 
in a half-area 96-well plate (Corning) with between 0.5 – 2.0% schizonts (enriched by magnetic LD columns 570 
(Miltenyi Biotec) (90, 91)). Cytospins were prepared immediately upon mixing the schizonts and target 571 
cells as well as 18 – 24 hours post invasion. Slides were stained with May-Grünwald-Giemsa as described 572 
and parasitemia was evaluated by reticle counting (92, 93). For invasion inhibition assays, the MEM6/6 573 
clone of the α-BSG antibody (preservative free) was used (Invitrogen) along with a matched isotype 574 
control antibody (preservative free) (Invitrogen). R1 peptide (63, 64) was prepared in complete RPMI 575 
media with 0.5% (w/v) albumax and 0.2% (w/v) sodium bicarbonate.  576 
 577 
  578 
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Figure Legends 594 
 595 
Figure 1. JK-1 erythroleukemia cell line models erythropoeisis, and homogenous populations of 596 
differentiated cells can be obtained by density sedimentation and FACS. (A) Cells at different stages of 597 
differentiation including proerythroblasts, basophilic erythroblasts, polychromatic erythroblasts (early 598 
and late) and orthochromatic erythroblasts (38, 94) were observed in a typical JK-1 cell culture. The 599 
dimensions of 50 - 100 cells of each of the stages was measured from stained images using Photoshop v. 600 
13.0. For each cell a measurement was made of both the longest (D1) and shortest (D2) diameter and the 601 
average (also indicated numerically) and standard deviation for each range are shown. (B) Layering of a 602 
mixed population of JK-1 cells on a 52.5% (v/v) Percoll-PBS gradient leads to the enrichment of early and 603 
late-stage polychromatic cells in the pellet fraction and retention of undifferentiated proerythroblast and 604 
basophilic cells at the interface. For all images, cells were stained with May-Grünwald-Giemsa and scale 605 
bars represent 10 μm. 606 
 607 
Figure 2. Screen of epigenetic library to identify inducers of JK-1 differentiation. (A) Heat-map showing 608 
the results of epigenetic screen for inducers of JK-1 differentiation. The signals have been normalized to 609 
the DMSO control (black arrow). Of the top 6 inducers (red bar), four of the compounds target 610 
bromodomain-containing proteins indicating a possible conserved mechanism of induction of 611 
differentiation. The full list of the 96-epigenetic modifiers is provided in Supplementary Table 1. (B) 612 
Validation of two of the top hits from the epigenetic screen (PFI-1 and (+)-JQ1) showing the fold expansion 613 
of undifferentiated JK-1 cells at different concentrations of compounds. Data shown are averages and 614 
standard deviations from three technical replicates from a representative biological assay.  615 
 616 
Figure 3. Generation of synchronous jkRBCs and comparison with cRBCs and peripheral RBCs. (A) Flow 617 
cytometry plots showing changes in expression of GypA and CD34 during differentiation for DMSO control 618 
treated cells, cells treated with 2.0 µM PFI-1 or 1.0 µM (+)-JQ1. (B) Representative microscopy images of 619 
differentiating cells stained with May-Grünwald-Giemsa. Scale bar on all images is 10 μm. (C) 620 
Demonstration of the homogeneity of induced JK-1 cells at 12 – 14 days post-induction with 2 µM PFI-1 621 
and post passage through 52.5% (v/v) PBS-Percoll gradients. Average and standard deviation from 10 622 
independent inductions are shown, with counts from at least 1000 cells per experiment. (D) Comparison 623 
of jkRBCs, day 16 cRBCs and peripheral RBCs. Representative microscopy images are shown alongside flow 624 
cytometry plots measuring the expression of known host receptors BSG, GypA, GypC, CR1 as well as the 625 
immature erythroid cell marker CD71. (E) The relative abundance of the 237 surface membrane proteins 626 
identified by quantitative surface proteomics was compared between jkRBCs and day 16 cRBCs. P values 627 
were estimated using Benjamini-Hochberg corrected significance A values as previously described for this 628 
approach (56, 87, 95) and proteins with highly significant fold change are indicated.  629 
 630 
Figure 4. JkRBCs support invasion of multiple strains of P. falciparum at levels comparable to cRBCs and 631 
RBCs. (A) Representative images of P. falciparum 3D7 and Dd2 parasites after successful invasion into 632 
jkRBCs. Scale bar on all images is 10 μm. (B) Parasitized erythrocyte multiplication rate (PEMR) values (% 633 
final ring parasitemia/% initial schizontemia) for P. falciparum 3D7 and Dd2 strains were similar between 634 
jkRBCs, cRBCs and RBCs. Average and standard deviation are from four biological replicates.  635 
 636 
Figure 5. Use of CRISPR/Cas9 to generate BSG knockout in JK-1 cells. (A) The ΔBSG clone has no surface 637 
expression of BSG but retains expression of known host receptors (GypA, GypC and CR1) at levels 638 
comparable to jkRBCs. Scale bar on all images is 10 μm. (B) Quantitative surface proteomics analysis 639 
comparing abundance of 237 surface membrane proteins between WT jkRBCs and ΔBSG jkRBCs confirm 640 
the specific loss of BSG in the ΔBSG cells. (C) ΔBSG knockout JK-1 cell line is refractory to P. falciparum 641 
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Invasion. Invasion of the sialic acid independent P. falciparum strain 3D7 and sialic acid dependent P. 642 
falciparum strain Dd2 was completely inhibited in two independent clones of ΔBSG. Data are normalized 643 
to invasion efficiency of wild type JK-1 cells and are representative of three biological replicates. Error bars 644 
represent standard deviations from 3 biological replicates. P values were calculated using a two-tailed T 645 
test (GraphPad Prism version 7.01). 646 
 647 
Figure 6. CD44 knockout results in a strain-transcendent reduction in parasite invasion. (A) Quantitative 648 
surface proteomics analysis confirming that the loss of CD44 in the ΔCD44 clone is specific. (B) Comparison 649 
of invasion efficiency between wild-type and two ΔCD44 knockout clones with multiple P. falciparum 650 
strains demonstrates a consistent reduction in invasion efficiency. Data for each parasite strain are 651 
normalized to invasion efficiency of wild-type JK-1 cells and are representative of between 2 – 3 biological 652 
replicates. Error bars represent standard deviations and P values were calculated using a two-tailed T test 653 
(GraphPad Prism version 7.01). (C) The ΔCD44 knockout has a reduced sensitivity to inhibition of invasion 654 
using the MEM6/6 α-BSG antibody suggesting a functional interaction between BSG and CD44 during 655 
parasite invasion. Data were normalized to invasion efficiency of the isotype controls and a representative 656 
plot is shown where error bars represent the standard deviation from three technical replicates. (D) 657 
Inhibition of invasion via dilution series of R1 peptide shows that the ΔCD44 knockout has a greater 658 
resistance to inhibition compared to the JK-1 wild type. A representative plot is shown with error bars 659 
representing standard deviation from three technical replicates. For both (C) and (D), IC50 values were 660 
calculated using a least-squares fit with log(inhibitor) vs normalized response and a variable slope using 661 
GraphPad Prism version 7.01. Below the plots, the average IC50 values for JK-1 and ΔCD44 are shown for 662 
three biological replicates (α-BSG, C) or four biological replicates (R1 peptide, D) with the standard error 663 
of the mean indicated in brackets. A paired, two-tailed T-test was used to calculate the P-value.  664 
 665 
 666 
  667 
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 669 
Parasite cell line generation 670 
The tdTomato sequence was amplified from a plasmid containing the tdTomato coding sequence (96) 671 
using the following primers: pCG110-F 5ʹ-AGTACCTAGGATGGTGAGCAAGGGCGAG and pCG111-RC 5ʹ-672 
AGTACTCGAGTTACTTGTACAGCTCGTCCATGC. The PCR product was digested with AvrII and XhoI (New 673 
England Biolabs) and cloned into pEcDamHI (97). For transfection, 100 µg of tdTomato containing plasmid 674 
were co-transfected with plasmid pINT into 3D7attB and Dd2attB parasites as described previously (98). 675 
Cultures were selected with G418 (125 µg/ml for Dd2 and 250 µg/ml for 3D7), 2.5 µg/ml blasticidin and 676 
2.5 nM WR99210 for 7 days after transfection followed by continuous selection with blasticidin and 677 
WR99210 alone. 678 
 679 
Generation of JK-1 shRNA knockdowns 680 
Lentivirus of the pLKO plasmid containing the shRNA against GYPA (TRCN0000116455) was obtained from 681 
the Broad Institute, Cambridge, MA. Lentiviral transduction into JK-1 cells was performed based on 682 
existing protocols used for CD34+ hematopoietic stem cells (14, 26). 683 
 684 
Quantitative Surface Proteomics 685 
The quantitative surface proteomics is based on previously described methods (56, 87). Briefly, 2 × 107 of 686 
each cell type were washed with PBS. Surface sialic acid residues were oxidized with sodium meta-687 
periodate (Thermo Fisher Scientific) then biotinylated with aminooxy-biotin (Biotium). The reaction was 688 
quenched, and the biotinylated cells incubated in a 1% Triton X-100 lysis buffer. Biotinylated glycoproteins 689 
were enriched with high affinity streptavidin agarose beads (Pierce) and washed extensively. Captured 690 
protein was denatured with dithiotreitol (SigmaAldrich), alkylated with iodoacetamide (IAA, Sigma) and 691 
digested on-bead with trypsin (Promega) in 200 mM HEPES pH 8.5 for 3 hours. Tryptic peptides were 692 
collected and labeled using TMT reagents (56). The reaction was quenched with hydroxylamine, and TMT-693 
labeled samples combined in a 1:1:1:1:1:1:1 ratio. Labeled peptides were enriched and desalted following 694 
which 75% of the total sample was separated into six fractions using tip-based strong cation exchange as 695 
previously described (56), and 10% of the total sample was subjected to mass spectrometry 696 
unfractionated. 697 
 698 
Mass spectrometry data was acquired using an Orbitrap Fusion coupled with an UltiMate 3000 Nano 699 
LC (Thermo Fisher Scientific, San Jose, CA). Peptides were separated on a 75 cm PepMap C18 column 700 
(Thermo Fisher Scientific). Peptides were separated using a 90 min gradient of 3 to 33% acetonitrile in 701 
0.1% formic acid at a flow rate of 200 nL/min (fractionated samples) or a 180 min gradient with otherwise 702 
identical parameters (unfractionated sample). Each analysis used a MultiNotch MS3-based TMT method. 703 
The scan sequence began with an MS1 spectrum (Orbitrap analysis, resolution 120,000, 400-1400 704 
Thompson, Automatic Gain Control (AGC) target 2 x 105, maximum injection time 50 ms). MS2 analysis 705 
consisted of Collision Induced Dissociation (CID) (quadrupole ion trap analysis, AGC 15,000, Normalized 706 
Collision Energy (NCE) 35, maximum injection time 120 ms). The top ten precursors were selected for MS3 707 
analysis, in which precursors were fragmented by HCD prior to Orbitrap analysis (NCE 55, max AGC 2 x 708 
105, maximum injection time 150 ms, isolation specificity 0.5 Th, resolution 60,000). Mass spectra were 709 
processed using a Sequest-based in-house software pipeline as previously described (56). Data were 710 
searched using the human Uniprot database (April 2014) concatenated with common contaminants (56), 711 
and filtered to a final protein-level false discovery rate of 1%. Proteins were quantified by summing TMT 712 
reporter ion counts across all peptide-spectral matches using an in-house software as previously 713 
described (56), excluding peptide-spectral matches with poor quality MS3 spectra (a combined 714 
signal:noise ratio of less than 250 across all TMT reporter ions). For protein quantitation, reverse and 715 
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contaminant proteins were removed, then each reporter ion channel was summed across all quantified 716 
proteins and normalized assuming equal protein loading across all samples. Fold change for each protein 717 
was calculated according to (average signal:noise (BSG knockouts) / average signal:noise (JK-1 controls)) 718 
or (signal:noise (cRBC sample) / average signal:noise (JK-1 controls)). Protein quantitation values were 719 
exported for further analysis in Excel. Gene Ontology Cellular Compartment terms were downloaded from 720 
www.uniprot.org and p-values (Significance A) calculated and adjusted with the Benjamini Hochberg 721 
method using Perseus version 1.2.0.16 (95). 722 
 723 
Comparison of RBC proteomes 724 
The complete list of 667 proteins identified in the quantitative surface proteomics was compared to 725 
published proteomes from the following publications: PMID 16861337 (99), PMID 18346024 (100), PMID 726 
24555563 (101), PMID 22954596 (102), PMID 19778645 (103), PMID 18494517 (104), PMID 18614565 727 
(105), PMID 27006477 (106), PMID 27452463 (57). Datasets were ranked by hierarchical clustering using 728 
Gene Cluster 3.0 (82) with an Euclidian distance similarity metric and visualized using TreeView v1.1.6r4 729 
(83).  730 
 731 
  732 
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Supplementary Table and Figure Legends 733 
 734 
Supplementary Table 1. Table of epigenetic modifiers tested for the ability to induce differentiation of JK-735 
1 cells. This table shows the epigenetic modifiers ranked by cluster analysis. The Cayman Chemicals 736 
(https://www.caymanchem.com/Home) catalogue number for each compound is listed. Chemical 737 
Abstract Service (CAS) numbers were obtained from Cayman Chemicals or from the SciFinder software 738 
(https://scifinder.cas.org/). Functional annotation of the targets of each compound was compiled from 739 
available literature and the compounds were grouped into the following target categories: histone 740 
acetyltransferases, histone deacetylases, histone methyltransferases, histone demethylases, DNA 741 
methyltransferases, sirtuins, bromodomains and others. 742 
 743 
Supplementary Table 2. Cell surface proteomic analysis of JK-1 WT, ΔBSG, ΔCD44 and cRBC lines. The full 744 
list of the 677 proteins identified from the surface proteomics analysis is shown in the ‘No_Filter’ 745 
worksheet. All proteins were identified from the SwissProt database with the exception of PNP, which 746 
was identified in the Trembl database. Classification of the identified proteins is given (UniProt ID, Gene 747 
Symbol, Description, Gene Ontology Cellular Compartment (GOCC)-term classification: M – membrane, 748 
PM – plasma membrane, IPM – integral to plasma membrane, CS – cell surface, XC – extracellular, Nuc – 749 
nuclear, ShG – short GO). ‘’Short GO’’ refers to a subset of proteins annotated by GO as “integral 750 
component of membrane”, but with no subcellular assignment (107). The number of peptides quantified 751 
for each protein is shown followed by the fold-change (FC) comparing the average signal:noise (S:N) from 752 
the two JK-1 WT samples to either the average S:N from the two ΔBSG knockout clones, or to the average 753 
S:N from the two ΔCD44 knockout clones or the S:N from the cRBC sample. The normalized S:N for each 754 
protein in JK-1 cells (WT, ΔBSG, ΔCD44) or cRBCs is finally shown. The ‘PM_CS_XC_ShG_2 peptides’ 755 
worksheet shows all 237 identified plasma membrane proteins, annotated either ‘PM’, ‘CS’, ‘XC’ or ‘ShG’. 756 
The ‘Mapping_Existing_Proteomes’ worksheet shows the presence or absence of the 677 proteins 757 
identified via surface proteomics with existing published RBC proteomes (indicated via PMID numbers).  758 
 759 
Supplementary Figure 1. (A) Images of ten different erythroleukemia cell lines during typical in-vitro 760 
culture: B4D6 (33); C2F8 (33); Ery-1 (31); HEL92.1.7 (36); K562 (32); LAMA-84 (34); OCIM (37); OCIM-2 761 
(37); TF-1A (35); and JK-1 (22). Scale bars are 20 µm. (B) Sorting of cells based on cell size parameter 762 
(forward scatter – FSC; side scatter – SSC) leads to the enrichment of differentiated cells in the small cell 763 
gate. The relative proportion of the different cell populations is shown in the bar beneath the microscopy 764 
image, color coded according to the key in Figure 1A. Scale bars are 10 µm. All cells were stained with 765 
May-Grünwald-Giemsa  766 
Supplementary Figure 2. (A) GypA levels increase as JK-1 cells differentiate. An undifferentiated 767 
population of JK-1 cells was stained with α-GypA-FITC antibody and sorted into GypA-positive and GypA-768 
negative fractions. GypA-negative cells correspond to undifferentiated proerythroblasts while GypA-769 
positive fraction correspond to differentiated polychromatic and orthochromatic cells. Relative 770 
proportion of the different cell populations is shown in the bar beneath the microscopy image, color coded 771 
according to the key in Figure 1A. Scale bar on all images is 10 μm. (B) Schematic of the epigenetic library 772 
screen. Undifferentiated JK-1 cells were obtained by sorting for α-GypA-negative population at Day 0. 773 
Cells were screened for five days (screen 1) or seven and fourteen days (screen 2) and differentiation of 774 
JK-1 cells was assessed by measuring the ratio of α-GypA-positive to α-GypA-negative cells. Plots of fold-775 
expansion (C) and microscopy images (D) for induction with either DMSO control, 2 µM PFI-1, 1 µM (+)-776 
JQ1, or a combination of 2 µM PFI-1 + 1 µM (+)-JQ1. The fold-expansion of the cells is higher in the 2 µM 777 
PFI-1 conditions. Addition of (+)-JQ1 alone or in combination with PFI-1 leads to reduced cell expansion 778 
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and a more distended cell morphology. Data in (C) are average and standard deviation from 2 replicates. 779 
Tranylcypromine maintains JK-1 cells in an undifferentiated state. (E) Growth curve of JK-1 cells treated 780 
with DMSO or with 10 µM tranylcypromine. Data are average and standard deviation of between 3 – 4 781 
biological replicates. (F) Treatment of JK-1 cells with 10 µM tranylcypromine maintains the cells in an 782 
undifferentiated state (compared to a DMSO-control) as shown by representative flow cytometry plots of 783 
cells stained with GypA, CD71 and CD34 over a course of 8 days.  784 
 785 
Supplementary Figure 3. Comparison of jkRBC cells to cRBCs and RBCs. (A) The longest (D1) and shortest 786 
(D2) diameters of day 16 cRBC cells at different stages of erythropoiesis and peripheral RBCs were 787 
measured from between 50 – 100 cells using May-Grünwald-Giemsa stained images. The average 788 
(indicated value) and standard deviations for each range are shown. (B) The relative proportion of 789 
erythroid cells from three independent cRBC cultures at 16/17 days post-thaw were measured from 790 
between 500 – 800 cells. (C) The 677 jkRBC proteins identified by quantitative proteomics were compared 791 
to published RBC whole proteome datasets as shown in the heatmap. The presence of a jkRBC protein in 792 
a published dataset is indicated by a blue box. The heatmap is split into two, where the right heatmap is 793 
a continuation of the bottom of the left heatmap. The following datasets were compared: PMID 16861337 794 
(99), PMID 18346024 (100), PMID 24555563 (101), PMID 22954596 (102), PMID 19778645 (103), PMID 795 
18494517 (104), PMID 18614565 (105), PMID 27006477 (106), PMID 27452463 (57). (D) Comparison of 796 
fold-change between cRBC and jkRBCs for blood group proteins identified by surface proteomics. The 797 
majority of cRBC proteins have relative abundance close to that found in jkRBC with a few exceptions (e.g. 798 
BCAM, SLC14A1, CD99). Proteins that are known to be associated with P. falciparum invasion are indicated 799 
in bold. (E) The propensity for multiple invasion events was determined via a selectivity index (SI) (61): 800 
higher SI indicates greater number of multiple invasions into a single host cell. The SI of jkRBCs was 801 
comparable to cRBCs but higher than RBCs. Average and standard deviation are from four biological 802 
replicates. 803 
 804 
Supplementary Figure 4. Growth of parasites in jkRBCs is impeded. (A) P. falciparum strain 3D7 parasites 805 
were purified using a Percoll gradient to enrich for late-stage schizonts and parasites were allowed to 806 
invade jkRBCs and RBCs for 4 hours at which time heparin was added to block further invasion (76, 108). 807 
Parasites were followed over one complete cycle and the proportion of rings, trophozoites and schizonts 808 
was evaluated by slide microscopy. Formation of trophozoites and schizonts was observed to be delayed 809 
in jkRBCs compared to RBCs. Data represent the average and standard deviation of two biological 810 
replicates. (B) Representative images of parasites during the experiment with the ring, trophozoite and 811 
schizont stage parasites indicated. Scale bar on all images is 10 μm. 812 
 813 
Supplementary Figure 5. Genetic manipulation of JK-1 cells.  814 
(A) An undifferentiated population of JK-1 cells was transduced with lentivirus targeting either GYPA or 815 
Luciferase (shLuc) as a control (14, 26). Flow cytometry analysis with α-GypA-FITC staining revealed a ~ 816 
20-fold knockdown (based on comparison of mean fluorescence intensity). (B) Generation of CRISPR/Cas9 817 
knockouts and validation of BSG knockout by TIDE (86) analysis. A schematic shows the steps in generating 818 
gene knockouts using JK-1 cells. Cells were transduced with a lentivirus containing the LentiCas9-Blast 819 
vector and then selected with blasticidin. The single-guide RNA was cloned into LentiGuide-Puro and this 820 
vector was transduced into the Cas9-expressing cells and cells were co-selected with blasticidin and 821 
puromycin. After two weeks of selection, cells were plated to obtain clones by limiting dilution. Deletions 822 
were validated by Sanger sequencing and TIDE analysis. (C) The ΔBSG-1 clone has two prominent deletions 823 
of -3 bp and -22 bp. (D) The ΔBSG-2 clone has two prominent deletions of -2 bp and -8 bp. (E) The location 824 
of the deletions was mapped based on the Sanger sequencing data and TIDE analysis.  825 
 826 
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Supplementary Figure 6. Generation of the ΔCD44 knockout line. (A) Domain structure of the full-length 827 
CD44 protein indicating the N-terminal hyaluronan binding domain in the extracellular region, the single-828 
pass transmembrane helix and the C-terminal cytoplasmic domain. Numbers below the figure represent 829 
amino acid positions. (B) Exon structure of CD44 and location of the CD44-1 sgRNA binding site. In the 830 
ΔCD44-1 and ΔCD44-2 clones we observe single base insertions (indicated in red bold type) that result in 831 
a premature stop codon (*) and a truncated protein. Importantly, the truncated protein does not have a 832 
transmembrane domain which is located in the C-terminus of the gene. (C) Representative microscopy 833 
images of wild-type jkRBCs and ΔCD44 knockout cells are shown. Flow cytometry comparison of levels of 834 
CD44, BSG, GypA, GypC and CR1 between wild-type and ΔCD44 knockout cells demonstrating specific loss 835 
of CD44 signal, while levels of other surface markers remains unaffected. Scale bar on all images is 10 μm. 836 
(D) Measurement of the relative flow cytometry signals for BSG and GypA in JK-1 WT and ΔCD44-1 837 
knockout line. Average and standard deviation from n = 4 independent experiments.  838 
 839 
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